CA3223733A1 - A process for the synthesis of 4-((r)-2-{[6-((s)-3-methoxy-pyrrolidin-1-yl)-2-phenyl- pyrimidine-4-carbonyl]-amino}-3-phosphono-propionyl)-piperazine-1 -carboxylic acid butyl ester - Google Patents

A process for the synthesis of 4-((r)-2-{[6-((s)-3-methoxy-pyrrolidin-1-yl)-2-phenyl- pyrimidine-4-carbonyl]-amino}-3-phosphono-propionyl)-piperazine-1 -carboxylic acid butyl ester Download PDF

Info

Publication number
CA3223733A1
CA3223733A1 CA3223733A CA3223733A CA3223733A1 CA 3223733 A1 CA3223733 A1 CA 3223733A1 CA 3223733 A CA3223733 A CA 3223733A CA 3223733 A CA3223733 A CA 3223733A CA 3223733 A1 CA3223733 A1 CA 3223733A1
Authority
CA
Canada
Prior art keywords
compound
process according
hci
mixture
amount
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CA3223733A
Other languages
English (en)
French (fr)
Inventor
Nicole Blumer
Romain CLAVEAU
Fabian Feyen
Leanne HALL
Stephen Hughes
Stefan Reber
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Idorsia Pharmaceuticals Ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA3223733A1 publication Critical patent/CA3223733A1/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65583—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA3223733A 2021-07-13 2022-07-11 A process for the synthesis of 4-((r)-2-{[6-((s)-3-methoxy-pyrrolidin-1-yl)-2-phenyl- pyrimidine-4-carbonyl]-amino}-3-phosphono-propionyl)-piperazine-1 -carboxylic acid butyl ester Pending CA3223733A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP2021069486 2021-07-13
EPPCT/EP2021/069486 2021-07-13
PCT/EP2022/069238 WO2023285342A2 (en) 2021-07-13 2022-07-11 A process for the synthesis of 4-((r)-2-{[6-((s)-3-methoxy-pyrrolidin-1-yl)-2-phenyl- pyrimidine-4-carbonyl]-amino}-3-phosphono-propionyl)-piperazine-1 -carboxylic acid butyl ester

Publications (1)

Publication Number Publication Date
CA3223733A1 true CA3223733A1 (en) 2023-01-19

Family

ID=82748669

Family Applications (1)

Application Number Title Priority Date Filing Date
CA3223733A Pending CA3223733A1 (en) 2021-07-13 2022-07-11 A process for the synthesis of 4-((r)-2-{[6-((s)-3-methoxy-pyrrolidin-1-yl)-2-phenyl- pyrimidine-4-carbonyl]-amino}-3-phosphono-propionyl)-piperazine-1 -carboxylic acid butyl ester

Country Status (10)

Country Link
US (1) US20240317784A1 (cg-RX-API-DMAC7.html)
EP (1) EP4370525A2 (cg-RX-API-DMAC7.html)
JP (1) JP2024524658A (cg-RX-API-DMAC7.html)
KR (1) KR20240033005A (cg-RX-API-DMAC7.html)
CN (1) CN117616033A (cg-RX-API-DMAC7.html)
CA (1) CA3223733A1 (cg-RX-API-DMAC7.html)
IL (1) IL309948A (cg-RX-API-DMAC7.html)
MX (1) MX2024000653A (cg-RX-API-DMAC7.html)
TW (1) TW202317140A (cg-RX-API-DMAC7.html)
WO (1) WO2023285342A2 (cg-RX-API-DMAC7.html)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2483072C2 (ru) 2007-11-29 2013-05-27 Актелион Фармасьютиклз Лтд Производные фосфоновой кислоты и их применение в качестве антагонистов рецептора p2y12
CN109715639B (zh) 2016-09-22 2022-04-19 爱杜西亚药品有限公司 结晶形式
SG11201908128YA (en) 2017-03-15 2019-10-30 Idorsia Pharmaceuticals Ltd Subcutaneous administration of a p2y12 receptor antagonist

Also Published As

Publication number Publication date
IL309948A (en) 2024-03-01
KR20240033005A (ko) 2024-03-12
MX2024000653A (es) 2024-01-31
EP4370525A2 (en) 2024-05-22
TW202317140A (zh) 2023-05-01
JP2024524658A (ja) 2024-07-05
US20240317784A1 (en) 2024-09-26
WO2023285342A3 (en) 2023-04-13
CN117616033A (zh) 2024-02-27
WO2023285342A2 (en) 2023-01-19

Similar Documents

Publication Publication Date Title
US11952341B2 (en) Method of preparing high chiral purity lactam intermediate and brivaracetam
EP0595345B1 (en) Process for producing alanylglutamine
KR101404893B1 (ko) 트랜스-4-[[(5s)-5-[[[3,5-비스(트리플루오로메틸)페닐]메틸] (2-메틸-2h-테트라졸-5-일)아미노]-2,3,4,5-테트라히드로-7,9-디메틸-1h-1-벤즈아제핀-1-일]메틸]-시클로헥산카르복실산
CN107922352B (zh) 制备蛋白质脱乙酰酶抑制剂的方法
EP0430336B1 (en) Process for the preparation of 4-O-phosphates of dopamine and dopamine derivatives
CZ2014502A3 (cs) Nová forma sofosbuviru a způsob její přípravy
JP7365349B2 (ja) 一酸化窒素を供与するプロスタグランジン類似体の製造方法
US5831086A (en) Production of cefotaxime and new sodium salts
BG63721B1 (bg) Метод за получаване на валацикловир и релевантни междинни продукти
WO2013177713A1 (en) Process for preparation of an antifolate agent
US20240317784A1 (en) Process for the synthesis of 4-((r)-2-{[6-((s)-3-methoxy-pyrrolidin-1-yl)-2-phenyl-pyrimidine-4-carbonyl]-amino}-3-phosphono-propionyl)-piperazine-1-carboxylic acid butyl ester
US20240262805A1 (en) Method for producing compound or pharmaceutically acceptable salt thereof
TWI826724B (zh) 用以製造1,5-苯并噻氮呯化合物之方法
EP3658569B1 (en) Process and intermediates for synthesis of peptide compounds
WO2008097483A2 (en) Methods for preparing aryl-substituted ketophosphonates
EP0262202B1 (en) Method for preparing penicillanic acid derivatives
CN111808040A (zh) 多构型2-氧代噁唑烷-4-羧酸类化合物的合成方法
KR860000586B1 (ko) 트리아진 유도체의 제조방법
KR20040105791A (ko) 트리테르펜 유도체의 제조 방법
CN101492431A (zh) 马来酸桂哌齐特的制备方法
WO2025257773A1 (en) Processes for the preparation of ritlecitinib and intermediates thereof
EP1163222A1 (en) Process of preparing 3s-3-amino-3-aryl propionic acid and derivatives thereof
HK40111936A (en) Method for producing compound or pharmaceutically acceptable salt thereof
SU891662A1 (ru) Способ получени карбометоксипроизводных 5(4)-аминоимидазол-4(5)-карбоксамида
RU1772103C (ru) Способ получени 2-аминобензонитрила

Legal Events

Date Code Title Description
MFA Maintenance fee for application paid

Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 2ND ANNIV.) - STANDARD

Year of fee payment: 2

MFA Maintenance fee for application paid

Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 3RD ANNIV.) - STANDARD

Year of fee payment: 3

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20250701

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20250701

MFA Maintenance fee for application paid

Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 4TH ANNIV.) - STANDARD

Year of fee payment: 4

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20260630

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20260630

D11 Substantive examination requested

Free format text: ST27 STATUS EVENT CODE: A-1-1-D10-D11-D117 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: REQUEST FOR EXAMINATION RECEIVED

Effective date: 20260709

P11 Amendment of application requested

Free format text: ST27 STATUS EVENT CODE: A-1-1-P10-P11-P101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: AMENDMENT RECEIVED - VOLUNTARY AMENDMENT

Effective date: 20260709

W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: A-1-1-W10-W00-W111 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CORRESPONDENT DETERMINED COMPLIANT

Effective date: 20260709

D00 Search and/or examination requested or commenced

Free format text: ST27 STATUS EVENT CODE: A-1-1-D10-D00-D118 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: REQUEST FOR EXAMINATION REQUIREMENTS DETERMINED COMPLIANT

Effective date: 20260731

D11 Substantive examination requested

Free format text: ST27 STATUS EVENT CODE: A-1-2-D10-D11-D155 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: ALL REQUIREMENTS FOR EXAMINATION DETERMINED COMPLIANT

Effective date: 20260731

P11 Amendment of application requested

Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-P102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: AMENDMENT DETERMINED COMPLIANT

Effective date: 20260731

P13 Application amended

Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P13-X000 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: APPLICATION AMENDED

Effective date: 20260731

W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: A-1-1-W10-W00-W111 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CORRESPONDENT DETERMINED COMPLIANT

Effective date: 20260731

Free format text: ST27 STATUS EVENT CODE: A-2-2-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT

Effective date: 20260731